Arkolith/Insider Trading/PCSA/Form 4

Yorke Justin W

DirectorProcessa Pharmaceuticals, Inc. (PCSA) · full profile →Form 4 · filed Jan 31, 2025
Net Buying
Open-Market Buys
$10K
Open-Market Sells
$0
Net Open-Market Flow
$10K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 27, 2025Buy(P)12K$0.80$10K12K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000897069-25-000153) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML